TY - JOUR
T1 - Chart validation of inpatient ICD-9-CM administrative diagnosis codes for acute myocardial infarction (AMI) among intravenous immune globulin (IGIV) users in the Sentinel Distributed Database
AU - Ammann, Eric M.
AU - Schweizer, Marin L.
AU - Robinson, Jennifer G.
AU - Eschol, Jayasheel O.
AU - Kafa, Rami
AU - Girotra, Saket
AU - Winiecki, Scott K.
AU - Fuller, Candace C.
AU - Carnahan, Ryan M.
AU - Leonard, Charles E.
AU - Haskins, Cole
AU - Garcia, Crystal
AU - Chrischilles, Elizabeth A.
N1 - Funding Information:
We thank contributors from the University of Iowa (Angela Overton, Erin Rindels, Michael Mueller, Nicholas Rudzianski, and James Torner), Harvard Medical School and Harvard Pilgrim Health Care Institute (Madelyn Pimentel, Meghan Baker, and Casey Covarrubias), Telligen —West Des Moines (Lois Pedelty and Kim Price), and Kaiser Permanente (Bruce Fireman). The results reported herein correspond to the objectives of Mini‐Sentinel contract HHSF223200910006I from the US Food and Drug Administration (FDA) and Department of Health and Human Services (HHS). This work was also supported by the Sentinel Coordinating Center, which is funded by the FDA through HHS contract number HHSF223201400030I.
Funding Information:
We thank contributors from the University of Iowa (Angela Overton, Erin Rindels, Michael Mueller, Nicholas Rudzianski, and James Torner), Harvard Medical School and Harvard Pilgrim Health Care Institute (Madelyn Pimentel, Meghan Baker, and Casey Covarrubias), Telligen—West Des Moines (Lois Pedelty and Kim Price), and Kaiser Permanente (Bruce Fireman). The results reported herein correspond to the objectives of Mini-Sentinel contract HHSF223200910006I from the US Food and Drug Administration (FDA) and Department of Health and Human Services (HHS). This work was also supported by the Sentinel Coordinating Center, which is funded by the FDA through HHS contract number HHSF223201400030I.
Publisher Copyright:
Copyright © 2018 John Wiley & Sons, Ltd.
PY - 2018/4
Y1 - 2018/4
N2 - Background: The Sentinel Distributed Database (SDD) is a large database of patient-level administrative health care records, primarily derived from insurance claims and electronic health records, and is sponsored by the US Food and Drug Administration for medical product safety evaluations. Acute myocardial infarction (AMI) is a common study endpoint for drug safety studies that rely on health records from the SDD and other administrative databases. Purpose: In this chart validation study, we report on the positive predictive value (PPV) of inpatient International Classification of Diseases, Ninth Revision, Clinical Modification AMI administrative diagnosis codes (410.x1 and 410.x0) in the SDD. Methods: As part of an assessment of thromboembolic adverse event risk following treatment with intravenous immune globulin, charts were obtained for 103 potential post–intravenous immune globulin AMI cases. Charts were abstracted by trained nurses and physician-adjudicated based on prespecified diagnostic criteria. Results: Acute myocardial infarction status could be determined for 89 potential cases. The PPVs for the inpatient AMI diagnoses recorded in the SDD were 75% overall (95% CI, 65-84%), 93% (95% CI, 78-99%) for principal-position diagnoses, 88% (95% CI, 72-97%) for secondary diagnoses, and 38% (95% CI, 20-59%) for position-unspecified diagnoses (eg, diagnoses originating from separate physician claims associated with an inpatient stay). Of the confirmed AMI cases, demand ischemia was the suspected etiology more often for those coded in secondary or unspecified positions (72% and 40%, respectively) than for principal-position AMI diagnoses (21%). Conclusions: The PPVs for principal and secondary AMI diagnoses were high and similar to estimates from prior chart validation studies. Position-unspecified diagnosis codes were less likely to represent true AMI cases.
AB - Background: The Sentinel Distributed Database (SDD) is a large database of patient-level administrative health care records, primarily derived from insurance claims and electronic health records, and is sponsored by the US Food and Drug Administration for medical product safety evaluations. Acute myocardial infarction (AMI) is a common study endpoint for drug safety studies that rely on health records from the SDD and other administrative databases. Purpose: In this chart validation study, we report on the positive predictive value (PPV) of inpatient International Classification of Diseases, Ninth Revision, Clinical Modification AMI administrative diagnosis codes (410.x1 and 410.x0) in the SDD. Methods: As part of an assessment of thromboembolic adverse event risk following treatment with intravenous immune globulin, charts were obtained for 103 potential post–intravenous immune globulin AMI cases. Charts were abstracted by trained nurses and physician-adjudicated based on prespecified diagnostic criteria. Results: Acute myocardial infarction status could be determined for 89 potential cases. The PPVs for the inpatient AMI diagnoses recorded in the SDD were 75% overall (95% CI, 65-84%), 93% (95% CI, 78-99%) for principal-position diagnoses, 88% (95% CI, 72-97%) for secondary diagnoses, and 38% (95% CI, 20-59%) for position-unspecified diagnoses (eg, diagnoses originating from separate physician claims associated with an inpatient stay). Of the confirmed AMI cases, demand ischemia was the suspected etiology more often for those coded in secondary or unspecified positions (72% and 40%, respectively) than for principal-position AMI diagnoses (21%). Conclusions: The PPVs for principal and secondary AMI diagnoses were high and similar to estimates from prior chart validation studies. Position-unspecified diagnosis codes were less likely to represent true AMI cases.
KW - diagnosis
KW - medical records
KW - myocardial infarction
KW - pharmacoepidemiology
KW - predictive value of tests
KW - validation studies
UR - http://www.scopus.com/inward/record.url?scp=85044793558&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85044793558&partnerID=8YFLogxK
U2 - 10.1002/pds.4398
DO - 10.1002/pds.4398
M3 - Article
C2 - 29446185
AN - SCOPUS:85044793558
SN - 1053-8569
VL - 27
SP - 398
EP - 404
JO - Pharmacoepidemiology and Drug Safety
JF - Pharmacoepidemiology and Drug Safety
IS - 4
ER -